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Asparaginyl Endopeptidases: Enzymology, Applications and 
Limitations 
TM Simon Tanga, Louis YP Luka,b* 
Asparaginyl endopeptidases (AEP) are cysteine proteases found in mammalian and plant cells. Several AEP isoforms from 
plant species were found to exhibit transpeptidase activity which is integral for the key head-to-tail cyclisation reaction 
during the biosynthesis of cyclotides. Since many plant AEPs exhibit excellent enzyme kinetics for peptide ligation via a 
relatively short substrate recognition sequence, they have become appealing tools for peptide and protein modification. In 
this review, research focused on the enzymology of AEPs and their applications in polypeptide cyclisation and labelling will 
be presented. Importantly, the limitations of using AEPs and opportunities for future research and innovation will also be 
discussed. 
Introduction
Asparaginyl endopeptidase (AEP) are proteases identified from 
the vacuole of plant cells.1 Also known as legumain,2,3 vacuolar 
processing enzyme1 or peptide asparaginyl ligase,4 AEPs react 
selectively at an internal asparagine (Asn) or aspartate (Asp) 
residue of a peptide backbone via a catalytic cysteine residue. 
In all cases, the enzymes are folded in the endoplasmic 
reticulum (ER) as a zymogen with a pro-domain which prevents 
substrate access to the active site.5–7 Pro-AEPs have been 
shown to accumulate in ER bodies within the epidermal cells of 
Arabidopsis thaliana seedlings.5 In response to stress, ER bodies 
fuse and release zymogenic AEPs into the vacuole.5  AEPs have 
also been reported to process seed storage proteins, 2S 
albumins, in prevacuolar multivesicular bodies (MVB) before 
reaching the protein storage vacuole in A. thaliana embryos.8 
The acidic environment within the MVB and vacuole trigger a 
proteolytic maturation to afford the active AEP (figure 1).2,5,7–10
Figure 1 Biosynthesis of AEP in plant cells. Zymogenic AEPs are produced in the ER and 
stored in ER bodies. The pro-enzyme is trafficked to the vacuole, where the acidic 
environment enables cleavage of the pro-domain resulting in activation.
Matured AEPs primarily function as peptidases which are 
associated with several critical cellular processes.2,11 Purified 
AEP from the seed of castor beans (Ricinus communis) have 
been shown to mediate the proteolytic processing of pro-
proteins to afford mature seed storage proteins including 2S 
albumin and 11S globulin.1,12 In vegetative organs, AEPs have 
been shown to facilitate programmed cell death.5,13 When an 
environmental stress (concentrated salt solution) was applied 
to healthy seedlings of A. thaliana, ER bodies were found to fuse 
and deliver AEPs to the vacuole, leading to cell death (figure 2).5 
While their structures and activity are similar to those of 
caspases,14–16 AEPs were also identified in mammalians, 
including humans and mice.2,17 Mammalian orthologues of 
AEPs, namely legumains, are associated with antigen processing 
which moderate antigen presentation and T-cell activity.18–20 
AEP-mediated proteolytic processing of the microbial tetanus 
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toxin antigen was found to enable antigen presentation by class 
II major histocompatibility complex molecules.18 
Figure 2 The peptidase activities of AEPs are involved in several critical cellular processes 
including seed maturation, programmed cell death and the regulation of antigen 
presentation.
Although most AEPs were shown to facilitate peptide cleavage, 
some AEPs isolated from plant species were found to exhibit 
peptide ligase activity.4,21–27 Ligase type AEPs are rare compared 
to the corresponding peptidases.4,21–23 Various plant species 
have been found to utilise this peptide ligase activity to facilitate 
post translational modification to produce backbone cyclised 
peptides (figure 3).4,22–24,26 The cyclisation step during the 
biosynthesis of kalata B1, a cystine knotted macrocyclic peptide, 
was shown to be catalysed by an AEP (OaAEP1b) in Oldenlandia 
affinis.22 Cyclic peptides found in plants exhibit a range of 
bioactivities,28,29 and demonstrate superior stability compared 
to their linear counterparts.30 Kalata B1 extracted from O. 
affinis, a native African plant species, demonstrates insecticidal 
activities inhibiting the growth of Helicoverpa punctigera larvae 
at a high concentration.31,32 Furthermore, the cyclic kalata B1 
have been shown to display high tolerance towards thermal 
(370 K, 97 °C) and chemical (8 M urea) denaturation.30 Another 
example of a cystine knotted cyclic peptide is Cter-M, which is 
cyclised by an AEP in butterfly pea plants (Clitoria ternatea), 
dubbed butelase 1.33 Other AEPs such as HaAEP1 from common 
sunflower (Helianthus annuus) and MCoAEP2 from gac fruit 
plants (Momordica cochinchinensis) have been reported to 
facilitate backbone cyclisation during the biosynthesis of cyclic 
trypsin inhibitor peptides SFTI-1 and MCoTI-II, respectively 
(figure 3). 27,34
Figure 3 Plant species utilise AEPs with ligase activities to generate backbone cyclised 
peptides with enhanced stability and bioactivity. Cter M (PDB: 2LAM) from C. ternatea, 
SFTI-1 (PDB: 1JBL) from H. annuus, MCoTI-II (PDB: 1IB9) from M. cochinchinensis and 
kalata B1 (PDB: 1NB1) from O. affinis. 
Reaction mechanisms of AEPs
Since the initial discovery of the AEP,1 there has been an 
expansion of research ranging from structural biology, 
enzymology to chemical biology development. X-ray 
crystallographic data of various AEPs have provided 
fundamental knowledge and rationales for the localisation of 
activity.4,7,10,35,36 Prominent structural features include the 
catalytic core domain which adopts a protein fold with a six-
stranded β-sheet surrounded by five α-helices. In the 
proenzyme, the catalytic site is covered by the pro-domain 
which is C-terminal to the core domain (figure 4).4,7,10,35,36 
Studies performed on an AEP from A. thaliana (AtLEGγ) 
revealed that pro-AEP adopts a dimeric state at neutral pH 
which has been shown to prevent enzymatic activation.7 The 
enzyme adopts a monomeric state at pH 4.0 and the 
protonation of salt bridges surrounding the active site of the 
AEP were reported to increase flexibility, enabling the auto-
proteolytic cleavage of the pro-domain to generate the active 
enzyme.5,7,22,35 Taken away from the acidic and reducing 
environments of the plant vacuole, the cleaved core domain 
and pro-domain of AtLEGγ have been shown remain bound in a 
two-chain state.7 The non-covalent association of the cleaved 






















































































































Journal Name  ARTICLE
This journal is © The Royal Society of Chemistry 20xx J. Name., 2013, 00, 1-3 | 3
Please do not adjust margins
Please do not adjust margins
AEP pro-domain was suggested to confer stability to the 
catalytic core domain at neutral pH.7
Figure 4 Overlaid ribbon representations of human pro-legumain (hLEG, PDB: 4FGU, 
purple), butelase 1 (PDB: 6DHI, orange), and OaAEP1b (PDB: 5H0I, blue) structures 
deduced from X-ray crystallography.10,35,36 The black dotted line indicates the separation 
between the pro-domain and the core domain. After activation, modified butelase 1 
(PDB: 6DHI) and OaAEP1b (PDB: 5H0I) structures showing only the catalytic core domains 
were overlaid with the crystal structure of activated human legumain (PDB: 4AWA, 
purple). In the box, an enlarged image of the active sites reveals the respective catalytic 
diads (Cys and His), the conformation adopted by the inhibitor (YVAD-CMK) in complex 
with activated human legumain, and a plant specific loop region referred to as the poly-
proline loop (PPL).26
The catalytically active core domain of AEPs have been 
proposed to operate via a mechanism that recruits the catalytic 
cysteine residue as a nucleophile.14,16,35 The catalytic diad (Cys 
and His) mediates a nucleophilic attack on the amide carbonyl 
of an internal Asn residue to form a thioester acyl-enzyme 
intermediate (scheme 1).22,23,25,35 For most AEPs, nucleophilic 
attack from a water molecule completes the peptide bond 
hydrolysis.35 For ligase-type AEPs, the N-terminal amine of an 
incoming peptide adopts the role of the nucleophile to resolve 
the thioester intermediate.22,23 The nucleophilic amine can be 
either from the same peptide, resulting in an intramolecular 
cyclisation,22,23 or from a different peptide, resulting in an 
intermolecular ligation.23,37 A mechanistic study of AEP-
mediated peptide ligation employing 18O-labelled water found 
no isotopic shift in the ligated peptide product.22,24 This finding 
indicated that water is likely to be excluded from the active site 
during peptide ligation by AEPs. Peptide ligation proceeds with 
a direct nucleophilic attack from the N-terminal amine to the 
thioester intermediate with no participation of solvent water 
molecules.
A succinimide motif not commonly seen among other enzymes 
has been observed by X-ray crystallography in active sites of AEP 
isoforms hLEG, HaAEP1 and AtLEGγ from human, sunflower and 
A. thaliana, respectively.25,35,38 The metastable structure 
resulted from the condensation between the sidechain 
carboxylate of Asp and a backbone amide NH. Nevertheless, 
Haywood et al. have shown that a mutation of the succinimide 
forming aspartate residue to an alanine bears no influence on 
the ligation activity of HaAEP1.25
Scheme 1. Proposed mechanism of AEPs catalysis with a Cys/His catalytic diad. AEP 
recognises and cleaves a peptide substrate containing Asn to form an acyl-enzyme 
intermediate via a tetrahedral intermediate. A nucleophilic attack resolves the thioester 
intermediate to afford the product peptide and the AEP is regenerated. The nucleophile 
can be a water molecule or the N-terminus of a peptide, resulting in peptide hydrolysis 
or ligation, respectively.
A comparison of AEPs from the same, or across multiple 
organisms, reveals that enzymes with ligase activities are 
uncommon compared to the putative proteases.4,21–23 Various 
AEP isoforms exhibit a remarkable difference in activity 
(protease vs. ligase) despite only subtle differences in sequence 
and structure.4,26,35,36 Furthermore, the activity of AEPs were 
reported to be influenced by the amino acid sequence, length 
of substrate peptides, plus reaction conditions such as pH.22,23,39
The growing library of AEPs identified from numerous 
organisms, accompanied by the increasing availability of 
sequence and structural information, has enabled comparative 
studies among isoforms and identification of features that 
influence the preference towards ligase or protease 
activity.7,26,27,36,39 Substrate accessibility to the active site of 
AEPs are governed by a gatekeeper residue (GK), also referred 
to as ligase-activity determinant 1 (LAD1),4 has been highlighted 
as a factor that determines activity (figure 5).10,26 The identity of 
this residue, with particular emphasis on the size of its 
sidechain, was suggested to influence substrate access to the 
active site. OaAEP1b, isolated from O. affinis, is an AEP variant 
which exhibits peptide ligase activity.22 Mutagenesis studies of 
OaAEP1b demonstrated that substitutions of the gatekeeper 
residue (Cys247) to larger residues such as Ile, Leu and Met 
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abolished ligase activity. In contrast, replacements with smaller 
Ala and Gly residues at the same position resulted in an increase 
in peptide cyclisation activity. In addition, the Cys247Gly 
mutation was shown to enhance peptide hydrolysis when 
compared to the wild-type and Cys247Ala variants.10 The 
smaller and less hydrophobic Gly as a gatekeeper residue was 
proposed to allow water molecules to access the active site, 
resulting in protease activity. The enhanced ligase activity of 
OaAEP1-C247A has consequently been adopted to facilitate 
protein labelling reactions in several studies.40–42
Figure 5 Key features associated with the determination AEP ligase and protease activity. 
Multiple sequence alignment of AEPs, from O. affinis (OaAEP1b, 3), P. x hybrida (PxAEP1, 
2, 3a, 3b), C. ternatea (butelase 1) and H. sapien (hLEG), centred around amino acid 
residues reported to influence activity. Catalytic diads (Cys/His) are shown in white 
letters with black highlight, N-glycosylation site is highlighted in green, the overlaid red 
boxes show LAD1 (gatekeeper/GK) and LAD2, blue box shows the plant-specific poly-
proline loop and the green box highlights the MLA.4,26 In the box, an enlarged overlaid 
image of OaAEP1 (PDB: 5H0I),10 butelase 1 (PDB: 6DHI)36 and human legumain (PDB: 
4AWA)35 active sites. Key features (catalytic diad, LAD1, LAD2, PPL and MLA) are 
rendered blue, orange and purple for OaAEP1, butelase 1, and human legumain 
respectively. In black, the conformation adopted by the inhibitor (YVAD-CMK) in complex 
with human legumain.
Further investigations into the sequence and structures of 
different AEP isoforms revealed additional polymorphic 
positions named ligase-activity determinant 2 (LAD2)4 and 
marker of ligase activity (MLA)26 which are located within, and 
adjacent to, the substrate binding pocket, respectively. The 
MLA was identified by a study comparing the sequences of 
protease and ligase AEPs from garden petunia (Petunia x 
hybrida) and describes a five amino acid deletion found in AEPs 
with ligase activity (figure 5).26 
The impact of the MLA on the peptide cyclisation activity in 
planta was investigated using tobacco plants (Nicotiana 
benthamiana) which co-expressed transgenes encoding for 
AEPs and corresponding peptide substrates. Relative cyclisation 
efficiencies in planta were measured by matrix-assisted laser 
desorption ionisation mass spectrometry (MALDI-MS).26 The 
insertion of five amino acid to the MLA region of OaAEP1b, a 
putative AEP ligase, was shown to significantly impede its ability 
to mediate peptide cyclisation.26 However, when the 
experiments were repeated in vitro, the MLA modification was 
found to only reduce the rate of peptide cyclisation by OaAEP1b 
rather than a distinct shift to protease activity.26 The truncation 
described as the MLA is also not found in the amino acid 
sequence of butelase 1, an AEP ligase from C. ternatea (figure 
5). Thus, while the MLA offer an indication to the protease vs. 
ligase preference of AEPs, it is not a critical determinant of 
enzyme activity.
LAD2 describes two amino acid residues lining the substrate 
binding pocket of AEPs. Mutation experiments performed in an 
AEP isolated from Viola yedoensis (VyPAL3) demonstrated the 
effect of amino acid substitutions at LAD2. Replacing Tyr with 
the smaller Gly residue was reported to improve the in vitro 
ligase activities of VyPAL3.4 Furthermore, a Tyr to Ala 
substitution at LAD2 of a protease AEP from Viola canadensis 
(VcAEP) was shown to shift enzyme activity from protease to 
ligase.4 However, the introduction of protease favouring 
residues at LAD positions did not switch the activity preference 
of VyPAL2, an AEP ligase from V. yedoensis, to adapt an increase 
of protease activity.4
None of the identified structural features were found to provide 
absolute control over the protease vs. ligase preference of AEPs. 
Nevertheless, mutations at gatekeeper, MLA and LAD2 have all 
been shown to significantly impact AEP activity.4,26 These 
findings suggest that key structural features may operate 
synergistically to dictate AEP activity, and further investigations 
are required to fully establish the key determinants of AEP 
protease and ligase activity. A recent review by Nonis et al. can 
provide further discussions towards the key determinants of 
AEP protease and ligase activity.43
Substrate recognition
Amino acid residues surrounding the peptide cleavage site for 
substrates of AEPs are commonly labelled following the 
numbering conventions adopted by Schechter and Berger for 
substrates of proteases (scheme 2).44 From the cleavage site to 
the peptide N-terminus, amino acid residues are numbered in 
ascending order starting from P1. On the other side of the 
cleavage site, amino acid residues are denoted with a single 
prime and numbered in ascending order towards the C-
terminus starting with P1’. For peptide ligation, the amino acid 
positions on the incoming peptide are labelled with a double 
prime and numbered in ascending order from the N-terminus 
starting with P1’’.
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Scheme 2 AEP-mediated transpeptidation, with amino acid residues numbered 
according to Schechter and Berger.44 The putative recognition sequences P1-P1’-P2’ and 
P1’’-P2’’ are coloured in blue and red, respectively.
Initial studies performed with an AEP isolated from castor beans 
have identified strict substrate specificity towards Asn at the P1 
position.1,2,17,18,22,23 The understanding of substrate recognition 
by AEPs have subsequently expanded with experiments in AEPs 
isolated from C. ternatea (butelase 1),23,45,46 O. affinis (OaAEP1b 
and OaAEP3–5)22,39 and other plant species.24,27 Substrate 
recognition by AEPs were shown to be determined mostly by 
amino acids at positions P1, P1’ and P2’ (scheme 2). While many 
AEPs have a strict preference towards Asn at P1, some isoforms 
such as HaAEP1 and OaAEP1b were found to accept Asp at 
P1.22,24 The preferences toward P1’ and the ensuing P1’’ from 
the nucleophilic peptide for ligation are non-specific. A peptide 
ligation assay which employed a library of peptides, with 
varying amino acids at the N-terminus, demonstrated that 
butelase 1 accepts all canonical amino acid residues at P1’’ with 
the exception of Pro.23 Furthermore, butelase 1 was reported to 
cyclise peptides with D-amino acids at P1’’ and recognise 
peptides with a thioester linkage between the P1 and P1’ 
residues.45,46 AEPs from O. affinis (OaAEP1b, OaAEP3–5) have 
been shown to process peptides with several different amino 
acid residues at P1’.22,39,47 In contrast, recognition at P2’ and P2’’ 
demonstrate greater specificity. While peptides with His or Ala 
at P2’ were not processed by OaAEP1b, peptide cyclisation was 
detected when substrates with Leu or Phe at P2’ were used.22,39 
Furthermore, butelase 1 was reported to ligate peptides with 
large, hydrophobic side chains such as Leu, Ile and Val at P2’’.23
Although most investigations towards the substrate specificity 
of AEPs have focused on the putative recognition sequences at 
P1-P1’-P2’ and P1’’-P2’’ (scheme 2), some studies suggested 
enzyme activity can be affected by other positions in the 
substrate peptide.22,27,48 A substitution of Arg with Ala at the P2 
position was found to significantly reduce the rate of OaAEP1b-
mediated peptide cleavage.22 Moreover, the use of Pro at P2 in 
a short peptide (5–9 amino acids) was shown to favour 
intermolecular ligation over intramolecular cyclisation by 
butelase 1. Intermolecular ligation of short peptides followed 
by head-to-tail cyclisation results in the formation of cyclo-
oligomers (scheme 3A).48 Notably, it was highlighted that 
butelase 1 was not able to recognise the corresponding cyclo-
oligomeric peptide products despite the presence of a suitable 
recognition sequence.48 Since AEP catalysis is not known to 
involve co-factors or other external sources of energy, this 
observation may be rationalised by conformational stabilisation 
of the cyclised peptide and an entropic gain from the release of 
the cleaved recognition peptide motif. 
Scheme 3 Peptide cyclisation catalysed by butelase 1. (A) Peptides greater than 9 amino 
acid residues in length and bearing the butelase 1 substrate recognition sequence (NHV) 
are cyclised by the AEP. Whereas peptides of 5-9 amino acid residues in length, with Pro 
at P2 and bearing the butelase 1 substrate recognition sequence (NHV) are ligated, then 
cyclised by AEP to afford cyclic oligomers.48 (only cyclo-dimer shown here) (B) Butelase 
1 was reported to cyclise the folded Somatropin (PDB: 1HGU) but not the denatured 
protein.49
The proximity of the N and C-termini was shown to influence 
the efficiency of AEP-mediated cyclisation of larger peptide and 
protein substrates. While butelase 1 was reported to effectively 
cyclise recombinantly prepared interleukin-1 receptor 
antagonist (IL-1Ra) and human growth hormone (somatropin), 
no cyclic proteins were detected when IL1-Ra and somatropin 
were denatured prior to incubation with the enzyme (scheme 
3B).37,49 A similar effect can also be observed in OaAEP1b-
mediated protein cyclisation of an intrinsically disordered 
protein, merozoite surface protein 2 (MSP2), which proceeds in 
low yield.39
Rate of peptide cyclisation by AEPs
The reported kinetic parameters for peptide cyclisation 
catalysed by various AEPs have been summarised in Table 1. As 
investigations have conducted the peptide cyclisation assays 
under different reaction conditions and substrates, it is difficult 
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to draw direct comparisons. Nevertheless, the catalytic 
efficiencies of AEPs are relatively high compared to sortase A, a 
widely used transpeptidase with catalytic efficiency (kcat/KM) 
values ranging from 0.02 to 2.80  104 M-1·s-1 for various 
engineered variants.50–52
With kcat/KM up to 131  104 M-1·s-1, butelase 1 extracted from 
C. ternatea is a highly efficient enzyme for transpeptidation 
(Table 1).23,37 The enzyme was reported to cyclise >95% of linear 
substrate peptide within 1 h at 37 °C (0.125 µM butelase 1 and 
50 µM peptide).23 On the other hand, OaAEP1b exhibits a lower 
kcat/KM than butelase 1.22 However, by replacing the gatekeeper 
(Cys247) near the active site with a smaller Ala residue, the 
engineered protein was shown to cyclise a model substrate 
peptide with kcat/KM value of 3.42  104 M-1·s-1 at pH 6.0 and 37 
°C.10 
Subsequently, a suite of AEP ligases from O. affinis (OaAEP3, 
OaAEP4 and OaAEP5) have been identified.39 OaAEP4 was 
reported to cyclise >95% of linear substrate peptide within 30 
min at room temperature (0.185 µM AEP and 280 µM peptide) 
with good tolerance to organic co-solvents (acetone, 
dimethylformamide and methanol). In directly comparable 
experimental conditions, OaAEP3, 4 and 5 all demonstrated 
greater kcat/KM than the prototypic OaAEP1b at pH 5.0 and room 
temperature. Further differences in the activity of AEPs from O. 
affinis were shown when the peptide cyclisation assay was 
performed at varying pH values. OaAEP4, the most active 
among all of the tested AEPs, offered optimal conversion of the 
linear peptide at pH 4.2 and remained active over a relatively 
narrow pH range (3.7-5.0). In contrast, OaAEP1b demonstrated 
optimal activity at pH 5.0 with a broader tolerance to pH 
compared to OaAEP4 (4.2-7.5). A 50% conversion to the cyclic 
peptide was detected when linear peptide substrates were 
incubated with OaAEP1b for 30 min at pH 7.5 (0.528 µM AEP 
and 280 µM peptide).39 
Applications of AEP ligase activity
The growing importance and diverse applications of protein 
science in contemporary research encompass a range of 
research topics including protein labelling for the study of post-
translational modification;53–56 protein-drug conjugation for the 
production of biopharmaceuticals;57–59 peptide ligation for the 
semi-synthesis of small proteins;60 bioconjugation to solid 
supports for the immobilization of proteins.61,62 The ability to 
facilitate peptide ligation and backbone cyclisation via a 
relatively short substrate recognition sequence, with good 
catalytic efficiency and tolerance to a broad pH range, highlights 
the significant potential of AEPs in applications.
Intramolecular ligation by AEP results in 
backbone cyclisation
Cyclisation often reduces conformational flexibility and imparts 
greater thermal and chemical stability.30,39,49,63 The joining of a 
peptide’s termini can provide resistance towards degradation 
by exopeptidases and improve the oral bioavailability of peptide 
products.29,30,49,64 Chemical approaches towards backbone 
cyclisation, such as native chemical ligation, are limited by strict 
requirements for N-terminal cysteines (or Cys-surrogates), C-
terminal thioesters and denaturing conditions.63,65,66 Similarly, 
the introduction of large split intein domains often impair 
solubility which limits the versatility of trans-protein splicing 
strategies.67,68 Cyclisation via small synthetic molecules have 
been employed to generate diverse libraries of cyclic peptides.69 
Chemical linkers with two thiol reactive functional groups were 
reported to bridge across two cysteine residues to afford cyclic 
peptide species and allow the insertion of non-native motifs.69 
However, this “chemical bridging” approach exploits the thiol 
reactivity of cysteine residues, which have limited selectivity 
when applied to cysteine-rich protein constructs.69 Moreover, 
the termini of bridged cyclic peptides remain unmodified, and 
thus susceptible to degradation by exopeptidases. The use of 
peptide ligases offers an alternative approach to peptide 
cyclisation. With excellent reaction kinetics and a short 
recognition sequence that is orthogonal to the existing enzymes 
such as the prolyl oligopeptidase, PCY1,70 and transpeptidase, 
sortase A,63,71 the addition of AEPs complements existing 
strategies. 
Peptide backbone cyclisation has been identified as the native 
function of AEP ligases isolated from plant species which produce 
cyclic peptides such as O. affinis (OaAEP1b),21,22 and C. ternatea 
(butelase 1).23 In nature, AEP ligases process the linear peptide 
precursors to afford the cyclic product which are typically around 30 
amino acids in length.64 Native and engineered AEPs derived from 
various plants have also been successfully employed to facilitate 
backbone cyclisation of peptides derived from other plant and non-
plant species such as kalata B1;21–23 sunflower trypsin inhibitor 
1;23,45,72 histatin-3;23 anti-malarial peptide R1;39 MCoTI-II;27 AS-48,72 
and proteins such as GFP;10,40,49 somatropin;49 MSP2;39 p53 binding 
domain.73 Butelase 1 was reported to generate the cyclic 
antimicrobial peptide θ-defensin and the cyclic conotoxin MrlA with 
>95% yield in 1 minute at 42 °C and pH 6.0.45 
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Table 1 Kinetic parameters of AEP for peptide backbone cyclisation
Assay conditions




/ 104 M-1·s-1 Temperature / °C pH
Ref.
Butelase 1 C. ternatea GI-Xn-NHV 26.55 131 42 6.0 23,49
OaAEP1b O. affinis GL-Xn-NGL 0.99 0.68 r.t. 5.0 39
OaAEP1-C247A O. affinis GL-Xn-NGL 13.9 3.42 37 6.0 10
OaAEP1-C247A O. affinis GL-Xn-NGL 1.52 1.04 r.t. 6.0 41
OaAEP3 O. affinis GL-Xn-NGL 0.61 33.0 r.t. 5.0 39
OaAEP4 O. affinis GL-Xn-NGL 0.76 98.4 r.t. 5.0 39




O. affinis GL-Xn-NGL 1.54 0.79 r.t. 6.0 41
xCeAEP1 C. ensiformis GR-Xn-NGL N.R. 0.58 37 5.0 24
MCoAEP2 M. cochinchinensis GG-Xn-NAL 19.86 62.1 22 6.0 27
Cyclotides, backbone cyclised and cysteine knotted peptides, 
have been touted as a potential scaffold for the development of 
novel therapeutics.27,29,49 The emergence of convenient and 
effective peptide cyclisation methods by AEPs have enabled the 
synthesis of grafted peptides, whereby bioactive peptides are 
inserted into cyclotides (figure 6).74 Exemplified by the 
cyclisation of MCoSST-01 using MCoAEP2,27,75 this approach 
employs the highly stable cyclic cysteine knot motif from 
cyclotides as a scaffold to deliver peptide pharmacophores.
Figure 6 Cartoon representation of a grafted cyclotide. A bioactive peptide (purple) is 
inserted into a cyclotide backbone, shown here using the structure of MCoTI-II (PDB: 
1IB9).
Applications of AEPs in protein research was demonstrated by 
the butelase 1-mediated cyclisation of the p53 binding domain, 
a potential target for anti-cancer therapeutics. The cyclic 
protein was reported to aid structural investigations by NMR 
and X-ray crystallography, methods that may be hindered by 
conformational flexibility induced line broadening and poor 
crystal formation, respectively.73 Furthermore, greater 
conformational stability in the cyclic protein was suggested to 
offer improved ligand binding due to a reduction of the 
associated entropic penalty.73 Protein cyclisation by AEP was 
also applied to MSP2 from Plasmodium falciparum, a 25 kDa 
protein for malarial vaccine development.39 When produced 
recombinantly, the protein is disordered and its antigenic 
behaviour no longer represents the native protein.76–78 OaAEP1-
mediated cyclisation of MSP2 was suggested to reduce disorder 
and potentially force the protein into adopting a conformation 
similar to the native antigen.39
Further developments in AEP-based technology can also be 
found in a recently published article that explored the effects of 
enzyme immobilisation (figure 7).72 The study illustrated that 
AEPs from C. ternatea (butelase 1) and V. yedoensis (VyPAL2) 
which were conjugated to a solid support offered greater 
stability in storage and repeated use for modifications of 
polypeptide including labelling and cyclisation. Significantly, 
immobilisation enabled the use of these enzymes at higher 
concentrations, and to perform peptide cyclisation reactions in 
continuous flow.72 The findings reported by Hemu et al. 
represent an advance towards adapting AEP catalysis for large 
scale and industrial applications.62
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Figure 7 Immobilisation of AEPs on solid support. AEPs, butelase1 and VyPAL2, have been 
immobilised on agarose beads via (A) NeutrAvidin-biotin affinity binding and (B) direct 
coupling to N-hydroxysuccinimide (NHS) ester with primary amines presented by lysine 
residues. (C) The immobilised AEPs were reported to facilitate ligation of proteins and 
peptides in continuous flow.
Intermolecular ligation by AEP for peptide and protein bioconjugation
Naturally occurring proteins commonly feature non-ribosomal 
modifications. Glycosylation, methylation, and lipidation can 
influence protein stability, localisation and interactions with 
other biological components.54,56,79–81 Protein modifications are 
routinely employed to study and engineer proteins beyond 
their native functions for academic research in addition to 
medicinal and industrial applications.55,82,83 Consequently, the 
development of novel polypeptide ligation technologies have 
been a growing theme in biological and organic chemistry 
research.51,52,58,84–99
Currently there is a range of chemical and biological approaches 
to bioconjugation.51,52,58,84–99 Chemical approaches tend to be 
more affordable, simpler to perform, but can be hindered by 
poor selectivity or the availability of specific reactive 
handles.93,94 Strategies employing enzymes offer an attractive 
alternative, whereby site-specific reactions can be catalysed 
under relatively mild conditions.95,96 Transpeptidase from 
Gram-positive bacteria (Sortase A),51,52,97 and other enzymes 
such as subtiligase,84,98,99 biotin ligase,85,86 transferases87–89 and 
formyl glycine generating enzymes58,90–92 have been employed 
for protein bioconjugation. Excellent kinetic parameters and 
relatively short recognition sequences indicate that AEP 
methodologies would be a valuable addition to supplement the 
existing approaches. AEPs have been employed to modify 
protein substrates including GFP,46,47,100 ubiquitin,37,46,101 
ompA,102 DARPin,101 maltose binding proteins,42,47 and 
nanobodies40 with  a range of synthetic labels including click 
handles, polyethylene glycol, fluorophores and drug molecules. 
Introduction of an isotopically labelled segment into protein 
backbone by OaAEP1b-mediated ligation was shown to enable 
NMR studies of maltose binding protein.47 The reported method 
uses a nicked protein, or self-assembling protein domains, to 
ensure close proximity between the ligating motifs, one of the 
factors that affects AEP-mediated ligation (scheme 4).47,100 
While preparation of labelled proteins by recombinant gene 
expression is routinely performed,103–105 this enzymatic 
approach offers the ability to selectively label specific regions 
within the protein. In addition, segmental isotopic labelling of 
proteins may find other applications such as elucidating protein 
dynamics.106–108 
Scheme 4 Ligation of self-assembling protein domains by OaAEP1b. Pre-organisation of 
the ligating substrates bring the reactive sites into close proximity, which was shown to 
affect AEP catalysis
Enzymes commonly target specific substrate recognition motifs 
defined by the active site. While AEPs have relatively non-
specific recognition at certain positions (P1’ and P1’’), changes 
in the recognition sequence have been shown to influence 
ligation efficiency.22,23,27,39,40 It was reported that, although Gly-
Val was accepted by OaAEP1 at the P1’’-P2’’ positions for 
ligation, the corresponding product (Asn-Gly-Val at P1-P1’-P2’) 
was poorly recognised for further enzymatic reactions (scheme 
5).40 This differential recognition of Val at P2’ vs. P2’’ was 
utilised to construct a protein bearing two different 
modifications at the N- and C-terminus mediated by a single 
AEP.40 Butelase 1 has also been employed in conjunction with 
sortase A to modify immunoglobulin molecules (IgG1) with two 
fluorescent tags (5,6-carboxyfluorescein and AlexaFluor 647) a 
one-pot dual labelling reaction.109 These reports highlight the 
potential use of AEPs in the semi-synthesis of more complex, 
multiply labelled protein such as antibody-drug conjugates.
Scheme 5 OaAEP1 recognises Val at P2’’, but not at P2’. Consequently, this feature in the 
substrate recognition of OaAEP1 has been exploited to prevent the undesired reverse 
reaction.
Finally, the reported application of butelase 1 for protein 
labelling on the surface of live bacteria exemplifies the 
biocompatibility of enzyme catalysis.102 The outer membrane 
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protein A (OmpA) of Escherichia coli strain BL21(DE3), modified 
with the butelase 1 recognition sequence at the C-terminus, 
was successfully labelled with tags such as 5,6-
carboxyfluorescein, biotin and the fluorescent protein 
mCherry.102 The ability to selectively modify proteins on the cell 
surface can offer an insight towards signalling mechanisms 
between cells and the extracellular matrix as well as 
intercellular communications.
Limitations of Using AEP as a Biocatalytic 
Tool
Preparation of recombinant AEP
While the utility of AEPs have been demonstrated through a 
number of examples, access to active enzyme has hindered the 
use of AEPs in biocatalytic applications. Butelase 1 was obtained 
via an arduous extraction and purification process from the 
native host, butterfly pea plant, for initial experiments.23,37 
Subsequently, procedures for the preparation of recombinant 
butelase 1 from bacteria (E. coli)36 and yeast (P. pastoris)73 were 
reported. Similarly, the preparation of recombinant OaAEP1b 
from E. coli culture have been reported in a number of 
studies.10,22,39,40
Mimicking the production and maturation of AEPs in nature, the 
recombinant AEPs are produced as a zymogen which can be 
activated at low pH (pH 3.6–4.0). The acidic environment 
simulates the plant vacuole, where active AEPs are known to 
accumulate in cyclotide-producing plant species.7,22,24,25 The 
gene construct employed to prepare recombinant OaAEP1b 
encodes for four distinct features: hexahistidine (His6) tag, 
ubiquitin, AEP core domain and pro-domain, producing a fusion 
construct. Located at the N-terminus, the His6 tag facilitates 
purification by immobilised metal affinity chromatography 
(IMAC). Between the His6 tag and AEP, the ubiquitin sequence 
has been employed to enhance solubility and expression levels 
of OaAEP1b and other AEPs.22,27 The pro-domain, a C-terminal 
section of the zymogenic AEP blocks substrate access to the 
active site, and thus silences enzyme activity. The pro-enzyme 
was isolated by IMAC, strong anion exchange (SAX) and size 
exclusion chromatography (SEC). Incubation at low pH (pH 4.0) 
was required to trigger the auto-proteolytic activation process 
(figure 8). In some studies, the activated AEP was subjected to 
a further purification step by ion-exchange 
chromatography.22,39,42 The reported yield of the activated 
OaAEP1b ranged between 1.8 and 2.0 mg/L from lysogeny-
broth (LB) media.22 Most of the procedures for preparing 
recombinant AEPs involved multiple purification steps and an 
incubation step at low pH. The time consuming and low yielding 
aspects of the procedure present a considerable limitation to 
the uptake of AEPs for bioconjugation applications. 
To address this issue, gene expression of different constructs 
have been tested.41 A construct based on OaAEP1-C247A that 
can be expressed without the pro-domain was identified. This 
has enabled the recombinant preparation of active and soluble 
AEP which can be isolated in only two chromatographic steps 
(figure 8). The purified enzyme demonstrated activities 
comparable to those of isolated with a pro-domain (Table 1). 
Nevertheless, the yield is relatively low (2.0 mg/L) in 
comparison to most recombinant protein preparation, and 
hence there remains substantial space for improvement.
Equilibrium in AEP-mediated peptide ligation
The ligation activity of AEPs have been employed to facilitate 
intermolecular ligation at either the N or C-terminus of proteins 
and peptides. While AEP mediated intermolecular ligation has 
been successfully employed in some cases, it operates with 
limited efficiency. Similar to other transpeptidases such as 
sortase A and trypsiligase,97,110–112 the challenge in preventing 
efficient AEP-mediated intermolecular ligation is that the by-
product dipeptide (P1’-P2’) acts as a competing nucleophile to 
reverse the ligation reaction.40,46 Water can also potentially 
serve as nucleophile, leading to hydrolysis. The efficiency of 
AEP-mediated ligations is affected by the proximity of the 
ligation partners and the rate of undesired reverse ligation.37 
Unlike intramolecular cyclisation, the ligating termini are 
unlikely to be in close proximity. Moreover, the entropic penalty 
from intermolecular ligation negates any entropic benefits from 
the release of the cleaved recognition peptide motif. 
Consequently, a large excess of the labelling peptide 
nucleophile is required to drive the ligation reaction to 
completion.37,40,46,101,109 The labelling of a nanobody protein 
using OaAEP1-C247A employed 25 equivalents of a fluorescent 
peptide label (250 µM), with respect to the protein (10 µM).40 
This rendered transpeptidase-mediated ligations 
uneconomical, especially when expensive or non-commercially 
available reagents are used (e.g. radioactive, isotopic or 
fluorescent labels).47,100,113,114
Attempts to address this limitation were made by exploiting the 
non-specific substrate recognition nature of AEPs.23,40,46,47,100,101 
The incorporation of self-assembling protein domains such as 
nicked-maltose binding protein or designed armadillo repeat 
protein was the only published approach which enabled 
effective conjugation without using an excess of labelling 
reagent.47,100 This method employed protein self-assemblies to 
bring the ligation partners into close proximity, thus improving 
ligation efficiency (scheme 4). However, the insertion of a large 
protein domain into the substrates limits the versatility of this 
approach. Therefore, a versatile method to enable effective 
AEP-mediated intermolecular ligation would unlock the 
tremendous potential of AEPs to a range of applications in 
protein sciences.
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Figure 8 Comparison of procedures for recombinant OaAEP1-C247A. (Red) Recombinant AEP preparation from the pro-enzyme involves multiple purification steps and an incubation 
period in acidic conditions (pH 4.0). (Green) Recombinant AEP preparation without the pro-domain enabled a streamlined method with less chromatographic steps and does not 
require activation. (IMAC) Immobilised metal affinity chromatography, (SAX) strong anion exchange and (SEC) size exclusion chromatography. X-ray crystal structure of OaAEP1b 
(PDB:5H0I) used here as a representative AEP
Butelase 1 have been reported to exhibit considerable 
reactivity towards synthetic peptide analogues bearing ester 
and thioester linkages (depsipeptide and thiodepsipeptide, 
respectively).46,101 This was exploited to develop an 
irreversible butelase 1-mediated ligation strategy (scheme 
6A).46 While the depsipeptide approach has been employed 
to ligate a synthetic peptide to the N-terminus of ubiquitin 
and green fluorescent protein (GFP) with good yields in 2.5 
h, the asparaginyl thiodepsipeptide motif have a short half-
life of around 45–75 min at pH 6.5 likely because of its 
susceptibility to rearrangement (scheme 6B).46,65 Owing to 
the hydrolysis of thiodepsipeptides, a five-fold excess of this 
unstable reagent was required to effectively label the target 
protein substrates.46 The use of an unnatural thioester motif 
further limits the application of this method to the labelling 
of protein N-termini.46
Without using unnatural (thio)depsipeptide motifs, the 
reverse reaction mediated by OaAEP1 can be prevented by 
taking advantage of the subtle difference in reactivity 
between two recognition sequences. Valine was reported to 
be an amino acid which is recognised at the P2’’ position, but 
poorly not at P2’. Thus, Gly-Val has been used as a 
recognition sequence on the nucleophilic peptide to 
generate a product peptide that is not readily hydrolysed by 
the enzyme (scheme 5).40 Nevertheless, a large excess of the 
nucleophilic peptide (20-fold excess) was required to obtain 
the ligated product in good yields.40
Scheme 6 Use of thiodepsipeptide for butelase 1-mediated ligation (A) Thioester 
linked Asn is accepted by butelase 1. Peptide ligation generates a peptide by-product 
with a α-thiol which is not recognised as a nucleophilic peptide substrate. As a result, 
the reaction was rendered irreversible. (B) Proposed mechanism for the hydrolysis 
of the unstable thioester.
Recently, reports that coupled AEP catalysis with chemical 
reactions have been made as an alternative approach to 
address issues related to reaction equilibrium and 
hydrolysis. In this first report, the recognition Asn-Cys-Leu 
was recruited to ligate with counterpart carrying a N-
terminal Gly-Leu by OaAEP1-C247A. Consequently, the 
enzymatic reaction can be driven by the addition of 2-formyl 
phenyl boronic acid (FPBA), which reacts with the released 
N-terminal cysteine to afford a non-reactive thiazolidine 
(scheme 7A).41 In another report, a His residue was 
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introduced to the P3’ position. Consequently, the peptide 
by-product from the OaAEP1-C247A reaction can 
sequestered by chelation with a divalent cation such as Ni2+ 
(scheme 7B). Quenching of the nucleophilic by-product 
prevents the reverse peptide ligation by OaAEP1-C247A, 
thus driving the reaction equilibrium towards product 
formation.42 Both of these reports are excellent proof of 
concepts facilitating protein labelling at the terminus of 
choice (N or C) with a lowered amount of label. Nevertheless, 
improvements are still required. Firstly, while the model 
peptide reactions showed significant improvement by the 
addition of a quenching agent (+40%), its enhancement was 
only moderate when applied to protein labelling (+20-30%). 
Furthermore, the quenching approaches do not address the 
undesired hydrolysis reaction associated with the protease 
activity of AEPs. Consequently, the reaction conditions (e.g. 
pH, enzyme concentration, amount of quenching reagent 
added, addition of reducing agents, reaction time) needs to 
be carefully screened to minimise unwanted hydrolysis 
reactions. Finally, the reagents employed to quench the 
nucleophilic by-product may result in off-target interference. 
For example, reactive aldehydes are commonly employed to 
introduce protein glycosylation.92 Therefore, FPBA may not 
be applicable towards glycosylated peptide labels. Similarly, 
the use of Ni2+ as a scavenger may also present issues when 
considering labelling proteins which contain a N-terminal 
His6 tag or utilise divalent metal co-factors such as Fe2+. 
Scheme 7 Nucleophile quenching strategies to enable effective peptide ligation by 
OaAEP1-C247A. (A) FPBA reacts with N-terminal cysteine to thiazolidine derivative 
to prevent reverse reaction. (B) Divalent Ni2+ quenches the nucleophilic peptide by-
product generated by OaAEP1-C247A, thus driving the reaction equilibrium towards 
product formation. The tripeptide motif Gly-Leu-His at the N-terminus coordinates 
to Ni2+
Conclusions
Asparaginyl endopeptidases possess a unique combination 
of features that draw attention from chemical biologists. 
They are catalytically efficient, and many can be produced 
using E. coli as the recombinant host. AEPs have a short 
recognition site, which is relatively non-specific at the P1’ 
position and more stringent at the P2’ site. These features 
together enable development of various polypeptide 
modification systems. However, most examples reported in 
the literature remain at the stage of proof-of-concepts, and 
great strides are needed in order to put AEPs forward into 
applications. Crucially, a simplified and high-yielding 
approach to recombinant AEP is essential. The AEP 
preparation procedure has recently been simplified to only 
two chromatographic steps with no incubation at low pH 
needed, yet the yield can be further improved by adapting 
advanced techniques such as use of an appropriate 
recombinant host and fermentation. Issues surrounding 
hydrolysis and reversibility also need to be addressed. The 
addition of scavengers to the AEP reaction appears to be a 
straightforward solution to prevent the reverse reaction, but 
its efficacy on protein labelling require further validation. 
Nevertheless, with significant advances in the structural 
biology and enzymology research of AEPs, they are 
anticipated to be widely adopted biocatalysts in the future 
to generate polypeptide derivatives that cannot be readily 
created by existing methods.
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